The Journal of Nutrition · Nov 20, 2026

Low-Carbohydrate, Animal-Centered Diets and Plant-Based Diets Exert Opposing Effects on Cardiometabolic Diseases

By Najjar RS

Low-carbohydrate, animal-centered (LCAC) diets are promoted for the prevention and treatment of type 2 diabetes (T2D) and cardiovascular disease (CVD) because randomized trials have shown short-term reductions in select risk factors, such as body weight, triglycerides, and glycated hemoglobin. However, controlled feeding studies have shown increases in low-density lipoprotein cholesterol (LDL-C), apolipoprotein B, and circulating free fatty acids with LCAC diets. Importantly, LCAC diets can also drive lipotoxicity and inflammation. These latter pathological biochemical effects directly act on pathways involved in the development of T2D and CVD. In contrast, high-carbohydrate, unrefined plant-based diets in these conditions reduce insulin requirements even without weight loss, lower blood pressure and medication use, and improve atherogenic lipoproteins and inflammation. Meta-analyses of randomized trials demonstrate reductions in LDL-C, apolipoprotein B, and glycated hemoglobin with vegetarian or vegan diets. Further, plant-based dietary interventions have also shown regression of coronary atherosclerosis and improvements in myocardial perfusion and cardiac function, an effect absent from LCAC diet literature. Thus, public health efforts aimed at the prevention and treatment of T2D and CVD should continue to focus on improving the quantity and quality of plant foods consumed rather than carbohydrate restriction alone.

doi.org/10.1016/j.tjnut.2026.101946PubMed 43064203Interventions

AgingResearch.News